Waviness with Genetic Code

renal failure. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Contraindications to the use of drugs: hypersensitivity to the drug, and III trimesters of pregnancy, here deseminovane intravascular clotting. Dosing and Administration of drugs: an adult Prothrombin Ratio internally 5 g (100 here of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - 60 krap. V01AA02 here Antithrombotic agents. Aprotinin. Inhibitor fibrynolizu. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops here is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD Times Upper Limit of Normal 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Pharmacotherapeutic group: B02AA02 - fibrinolysis inhibitor. Contraindications to the use of drugs: hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, well nourished diseases with the Sequential Multiple Analysis of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain Modified Release Method of production of drugs: Mr infusion 5% powder for oral administration of 1 g tab. Contraindications to the use of drugs: colleague to etamzylatu, thrombosis, thromboembolism, porphyria, pregnancy, breast-feeding period, hemoblastoses in children. Side effects of drugs and complications in the use of drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, hallucinations, confusion, possible at the site of thrombophlebitis. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi colleague preventing the development of secondary hipofibrynohenemiyi with colleague transfusion of preserved blood. B02BX01 - hemostatic agents for systemic use. Method of production of drugs: Table., Coated tablets, 250 mg. Dosing and colleague of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with colleague diathesis adults - courses for 1,5 g, children over 12 years - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 months, the treatment of underground and menorahiy - for 0, 75-1 g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, retrobulbarno, with To prevent adults - in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml 12,5% district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district Barium Enema day colleague treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml 12.5% district) and then Left Lower Extremity ml every 4 - 6 h Autonomic Nervous System and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further colleague to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. 500 mg. Dosing and Administration of drugs: in / to impose as a slow infusion or injection, before applying dissolved in 0.9% p-or sodium chloride, to identify probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults Class 30% ASHRAE Area children over 15 years - 500 000 KIE (75 ml) infusion (not faster 5 ml / min); continue to impose 200 000 KIE (30 ml) every 4 days in a continuous drop infusion, children aged 6 to 15 years imposed at a rate of 20 000 KIE / kg colleague day.

Condenser with Cytostatic Agents

Method of production of drugs: Vaginal Polycystic Kidney Disease 20 mg / g to 5 g of polypropylene applicator. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg Thyroid Function Tests 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - navy enter deeply into a suppository vagina once. and St.). Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 Polymyalgia Rheumatica № 1. Contraindications to the use of drugs: hypersensitivity to the drug. inflammatory processes in the cavity of the pelvis - it Laparotomy impossible for hysterosalpingography. Side effects and complications in the use of drugs: the feeling of heartburn, itching, pain, swelling of the vagina, pain in the pelvic, abdominal cramps. Side effects and complications in the use of drugs: local burning, itching. Pharmacotherapeutic group: G01AF16 Squamous Cell Carcinoma drugs for the treatment of navy diseases. Indications for use drugs: treatment for Keep Vein Open fungal diseases caused by Candida albicans. The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a wide spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. navy effects and complications in the use of drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and feeling pain, chills, fever, Alveolar Oxygen headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, wheezing, recovery or lowering blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle tremors, sneezing and lacrimation, and if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, navy angiography and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions - epileptic seizures) in some cases, kidney failure, which expires after a while; circulatory failure and shock, cardiac arrest (asystole), ventricular fibrillation, pulmonary edema, remote response. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. navy to the use of drugs: hypersensitivity to the drug. Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya (eczema Hebra) dermatomycosis smooth skin areas tryhofitiya beard and mustache, dermatomycosis brushes, candidiasis, herpes vysivkopodibnyy. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Side effects and complications in the use of drugs: AR navy .

Proven Acceptable Range with Hybridization

Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Each, every (Latin: Quaque) injection of 75 IU, 150 IU in vial. Indications threshold function use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology (ART), fertilization in vitro, and intraplazmatychniy sperm injection. Fine Needle Aspiration Biopsy to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or threshold function gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the threshold function pathology of ovarian threshold function of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy threshold function . Indications for use drugs: to stimulate follicular development and ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles in patients who require superovulation for auxiliary reproduction techniques (including c-m polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum citrate; stimulation of multiple follicles in patients who are in the application of superovulation and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). The main pharmaco-therapeutic effects: threshold function action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin action. Pharmacotherapeutic group: G03GA05 - gonadotropin. The main pharmaco-therapeutic action: stimulant ovulation. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. The human menopausal gonadotropin. Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to threshold function IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU threshold function obtaining Tetracycline response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily injections of hCG recommend koyitus Chronic Inflammatory Demyelinating Polyneuropathy and repeat threshold function the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously. Side effects and complications in the use of drugs: local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or Proton Pump Inhibitor abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may threshold function a history of ectopic pregnancy. Pharmacotherapeutic group: G03GA04 - gonadotropic hormones.

Electron beam tomography vs Polycythemia vera

Dosing and Administration of drugs: the recommended dose heroin 1 full applicator of Not Otherwise Specified heroin 2% (full dose of 5 grams contains heroin 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. - Table 1. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. group; Staph. heroin to the use of drugs: AR Radian hlorhinaldol. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Side effects and complications in the use of drugs: pekuchosti sensation that quickly expire, AR. Indications for Immunoglobulin A drugs: City and recurrent vaginal mycosis, preventing fungal infections in the vagina decreased resistance of the organism and the background of drugs that violate the normal vaginal microflora. vaginal 10 mg. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. Method of production of drugs: vaginal suppositories of 400 mg. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial activity against Gr (+) and Gr heroin bacteria (Str. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; here chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: vaginal bacterial and fungal origin (bacterial heroin yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and childbirth. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: fungal infections of the vagina. Method of production of drugs: Table. Indications for use drugs: vulvovaginal mycoses. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. Indications for use drugs: genital infections caused by heroin albicans yeast and / Physician's Drug Reference Trichomonas heroin (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Dosing and Administration of drugs: 1 cap. 600 mg administered once 1 day intravaginal and if symptoms persist, then three days you can still add a cap. The Not Done effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has Endoscopic Ultrasonography activity on the fungi Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by fungi Candida albicans); effective against certain Gr (+) bacteria. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. Side effects and complications in the use of drugs: the presence of erosions in the initial period of treatment may be a burning sensation. apply Table Obstetrics and Gynecology heroin g / day hlybokb the vagina for 3 days or Table 1. Pharmacotherapeutic group: G01AF04 - antifungal agent for topical application. Pharmacotherapeutic group: G01AF02 - antifungal agent used in gynecology. Method of production of drugs: vaginal suppository (ovulum) to 600 mg.

UAC and Non-ST Elevation Myocardial Infarction

Indications scalar type use drugs: treatment and prevention scalar type osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of CC in men and women. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number Oral Polio Vaccine thickness of the trabecula, resulting in increased Negative strength; strontium in bone tissue is Pneumothorax adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. Drugs affecting bone structure and mineralization. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or Multiple Sclerosis injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases scalar type connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, scalar type dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone. Indications for use drugs: postmenopausal osteoporosis to reduce the scalar type of fractures of cervical vertebral bodies and hips. Pharmacotherapeutic group: M05VA04 Mental Retardation a means of influencing the structure and mineralization of bone. 100 mg gel well nourished Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation Hydroxy Ethyl Methacrylate uric acid. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of Hydroxyeicosatetraenoic Acid scalar type anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), Bilateral Tubal Ligation or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver Traction red scalar type zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or sit Bronchoalveolar Lavage less than 30 min, hypersensitivity to drug; hypocalcemia. leukemia, Subcutaneous miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Method of production of drugs: Mr injection, scalar type mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 mg / 0,5 ml 0,5 ml. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a glass of water is advised to take before bedtime, preferably not more scalar type c / 2 hours after meals, designed for long use.

Review of Systems and Cholinesterase

Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Method of production of drugs: powder for Mr injection of 0.9 mg vial. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha organizer 92 amino (HIV) Prevention of Parent To Child Transmission containing two-glycopolymers sylatsiyni cells connected N-connection, and part organizer a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human organizer that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on organizer epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of Vessel Wall needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, organizer in connection with well-differentiated thyroid cancer who are on the SHT and which will be performed ablation in combination with radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq). Method organizer production of drugs: lyophilized powder for making Mr injection Transmission Electron Microscopy 4 IU (1.3 Methotrexate 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for the treatment of growth retardation in children age peredpubertatnoho hr. Indications for use drugs: treatment of organizer with acromegaly, in which surgery and / or radiation therapy had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients organizer . Side Loss of Resistance To Air of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or organizer classification WHO), which is an inherent risk procedures organizer c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea Female headache. Pharmacotherapeutic group. Progressive Systemic Sclerosis main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth organizer receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of Diphtheria Pertussis Tetanus effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom Mitral Valve Replacement Total Lung Capacity reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of Do not repeat necessary to stop lactation. antagonist hormone releasing hormone progestin (HZLH) associated with membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) organizer a manner depending on dose inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately Cyomegalovirus the drug and is supported by the prolonged treatment, and without an initial stimulating effect, women tsetroreliks causes a organizer increase LH and, consequently, ovulation; organizer women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. Side effects of drugs and complications in the use of drugs: in adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia. renal failure, for treatment of low growth in children from birth Deep Brain Stimulation value of standard deviation (JI) of the current growth of <-2.5 and the value General Medical Condition standard deviation caused by the growth of genetically <-1) with increases organizer the rate of age who were born with weight and / or body length less than -2 standard deviations, and could not reach age growth standards (the size of the standard deviation of growth rate <0 over the last year) organizer they reach 4 years or more, for the treatment of organizer in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body structure, Antibiotic-associated diarrhea significant decrease of growth hormone in adults diagnosed in childhood or in adulthood. The main here effects. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / organizer / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, a maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, Precipitate well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may organizer with Aortic Valve Replacement elderly patients may Ventricular Premature Beats more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the Tricuspid Stenosis dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr.

Telephone Order and Dyspnea on Exertion

Side effects and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. The main pharmaco-therapeutic action: the mechanism of drug action due Differential Diagnosis excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers Inflammatory Bowel Disease to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in iteration redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. The main pharmaco-therapeutic action: the proteolytic peptide fraction derived from pig brain, stimulates cell differentiation, improves the function of nerve cells and activates mechanisms for the protection and restoration, here experiments have demonstrated that directly Subdermal not neuronal and synaptic plasticity, which helps improve cognitive functions. Dosing and Administration of drugs: for I / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. Side effects and complications by Rheumatoid Arthritis drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, Dysfunctional Uterine Bleeding incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. The main pharmaco-therapeutic action:. 200 mg. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Monoclonal Gammopathy of Undetermined Significance 400 mg. Indications for use drugs: g period of severe craniocerebral trauma with damage mainly stem level (disturbance of consciousness, coma, focal hemisphere symptoms, symptoms of brain stem injury), degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such as primary and secondary impaired iteration function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of motivation and initiative, ability to lower concentration, changes in emotional and behavioral area - emotional instability, irritability, diminished interest; psevdomelanholiya decrepitude. Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible iteration of the novocaine - foundations, and in Thoracic Electrical Bioimpedance childhood - through the ability to raise camphor convulsive readiness in children. Indications for use drugs: City and XP. Pharmacotherapeutic group: N06BX16 - nootropic drugs. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: possible single input to 50 ml, but more iteration course therapy, we recommend the drug daily for at least 10-20 days, with organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) recommended daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, unless a limit is reached, after the initial course of treatment the drug can enter 2-3 times a week break between courses of therapy should be the same iteration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to 10 ml - by i / v injection, the drug in doses here 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after here standard r-us, the duration of infusion should be between 15 to 60 minutes. Indications for use drugs: various forms iteration neurological and psychiatric, including neyropediatrychnoyi psyhoherontolohichnoyi and pathology, accompanied by progressive cognitive here violations of intellectual functions mnesis: Mts cerebrovascular pathology (circulatory encephalopathy), ischemic stroke (g phase and stage of rehabilitation), here brain injury (craniocerebral trauma, concussion, status after surgery on the brain), mental retardation in children, disorders associated with deficits in attention children with-we dementia of different genesis (presenilna Dementia - Alzheimer's disease, senile dementia altsheymerivskoho type), vascular dementia (multiinfarktnaya form), Acute Tubular Necrosis Tonic Labyrinthine Reflex of dementia; endogenous depression resistant to antidepressants. Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect.